Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bacterial complementation as a means to test enzyme-ligand interactions

B Canyuk1, S P Craig, A E Eakin

  • 1Laboratory of Molecular Parasitology and Drug Design, Division of Medicinal Chemistry and Natural Products, School of Pharmacy, University of North Carolina at Chapel Hill 27599-7360, USA.

Applied Microbiology and Biotechnology
|October 9, 1998
PubMed
Summary

A novel bacterial complementation assay enables rapid screening of compounds targeting hypoxanthine phosphoribosyltransferase (HPRT). This method aids in identifying potential drug candidates for parasitic diseases through structure-based inhibitor design.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Considerations for Dose Selection and Clinical Pharmacokinetics/Pharmacodynamics for the Development of Antibacterial Agents.

Antimicrobial agents and chemotherapy·2019
Same author

A Nd(3+)-doped cw fiber laser using all-fiber reflectors.

Applied optics·2010
Same author

Cascade Raman soliton fiber ring laser.

Optics letters·2009
Same author

The role for glutamic acid at position 196 in human hypoxanthine phosphoribosyltransferase (HPRT) as investigated using site-directed mutagenesis.

Nucleosides, nucleotides & nucleic acids·2008
Same author

Mechanism of action of the antitumor agents 6-benzoyl-3,3-disubstituted-1,5-diazabicyclo[3.1.0]hexane-2,4-diones: potent inhibitors of human type II inosine 5'-monophosphate dehydrogenase.

International journal of cancer·2001
Same author

Investigation of the functional role of active site loop II in a hypoxanthine phosphoribosyltransferase.

Biochimica et biophysica acta·2001

Area of Science:

  • Biochemistry
  • Parasitology
  • Drug Discovery

Background:

  • Hypoxanthine phosphoribosyltransferase (HPRT) is a key enzyme in purine metabolism.
  • HPRT is a potential drug target for treating parasitic diseases caused by organisms like Plasmodium falciparum and Trypanosoma cruzi.
  • Structure-based inhibitor design requires efficient screening methods for identifying novel drug leads.

Purpose of the Study:

  • To develop and validate a rapid bacterial complementation assay for screening enzyme inhibitors.
  • To identify compounds that inhibit HPRT from parasitic sources for potential therapeutic development.
  • To assess the utility of this assay in structure-based drug design efforts.

Main Methods:

  • A bacterial complementation assay was established using genetically deficient bacteria.

Related Experiment Videos

  • Active, recombinant HPRT from Plasmodium falciparum, Trypanosoma cruzi, and human sources was used for complementation.
  • Compounds were screened by measuring bacterial growth in selective medium via absorbance.
  • IC50 values were determined to quantify compound inhibition of bacterial growth, reflecting enzyme inhibition.

    • Main Results:

    • The bacterial complementation assay successfully identified compounds inhibiting HPRT activity.
    • The assay demonstrated efficacy in screening against parasitic HPRT enzymes.
    • Results correlated compound effects on bacterial growth with enzyme inhibition potential.

    Conclusions:

    • The developed bacterial complementation screening assay is effective for rapid identification of enzyme inhibitors.
    • This assay is a valuable tool for structure-based drug design targeting enzymes like HPRT.
    • The method facilitates the discovery of potential therapeutics for parasitic infections.